Inside BioStack's $9.5M Seed Round: Building a Global Clinical Data Layer
Dr. Dereck Mush, MD, MBADCVC
Venture fund
- Stages
- Seed, Series A, Growth
- Cheque size
- Not disclosed
- Based in
- Palo Alto, CA, USA
- Focus
- Deep tech, Healthcare data, Biotechnology
DCVC participated in BioStack’s October 2026 seed financing. Its investment approach spans deep computing, data infrastructure and science-driven businesses.
Backs deep technology companies applying advanced computing, data and scientific innovation to large industries.
Notable investments
- BioStack
Investors at similar stages
- 7wireVentures
Venture fund
- Andreessen Horowitz Bio + Health
Venture fund
- Bessemer Venture Partners
Venture fund
- Catalyst Health Ventures
Venture fund
- CommonSpirit Ventures
Health system venture investor
- CVS Health Ventures
Corporate venture
Related on The Signal
Dr. Dereck Mush, MD, MBA
Direct AI Record Access: What TEFCA Changes and What It Does Not
Dr. Dereck Mush, MD, MBA
Next-Gen Neurotechnologies: Graphene Electrodes and Magnetic Surgical Robotics in Deep Brain Neuromodulation
Dr. Dereck Mush, MD, MBA
The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBAKeep exploring